Trends in Cancer
Volume 2, Issue 4, April 2016, Pages 163-165
Journal home page for Trends in Cancer

Spotlight
Melanoma, Viagra, and PDE5 Inhibitors: Proliferation and Metastasis

https://doi.org/10.1016/j.trecan.2016.02.007Get rights and content

Inhibitors of the cGMP-degrading phosphodiesterase (PDE) 5 have achieved blockbuster status in the treatment of penile erectile dysfunction (PED). Their repurposing is currently being proposed to treat certain solid tumours and various other diseases. In cruel irony, however, it appears from recent clinical studies that PDE5 inhibitors may increase the risk of malignant melanoma by negating newly identified brakes on proliferation and metastasis provided by PDE5A.

References (10)

There are more references available in the full text version of this article.

Cited by (7)

View all citing articles on Scopus
View full text